window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-4PR1PSYQLJ'); Skip to content

Welcome to Discover Pharma! Today is : April 20, 2026

  • News
  • Featured News Archives
    • 12 Days of Christmas
    • Women in Pharma
  • About Us
Contact Us

Phase 3 Trials

  • Biotech,Clinical Development,Clinical Trials,Healthcare leadership,Immunology,Movers & Shakers

    Aravax adds allergy specialists to board as peanut therapy advances

    Aravax has appointed two senior industry figures to its board [...]

    April 8, 2026
  • Clinical Trials,Research & Development,Respiratory

    Tozorakimab meets primary endpoint in two Phase 3 COPD trials, showing reduction in exacerbations

    Tozorakimab has met its primary endpoint in two replicate Phase [...]

    March 27, 2026
  • Biomanufacturing,Clinical Trials,European biotech,Pharmaceuticals and therapeutics,Regulatory Affairs,Supply Chain & Logistics

    Klifo receives regulatory approval for new clinical trial supply facility in Copenhagen

    KLIFO, Europe’s largest independent provider of clinical trial supply (CTS) [...]

    October 9, 2025
  • Clinical Development,Clinical studies,Data Management,Technology and platforms

    REDCap Cloud 2.0 launched to harmonize clinical trial and real-world data for AI-driven research

    REDCap Cloud has launched version 2.0, a clinical trial data [...]

    September 24, 2025
  • Clinical Development,Clinical Trials,Dermatology,Pharmaceuticals and therapeutics

    Icotrokinra shows superiority to deucravacitinib in first head-to-head Phase 3 trials for plaque psoriasis

    Johnson & Johnson has reported new data from the Phase [...]

    September 23, 2025
  • Clinical Development,Clinical Trials,Data Management,Patient Centricity,Real world evidence,Research & Development

    TransCelerate and Tufts study finds nearly one-third of clinical trial data adds limited value

    A new collaborative study from TransCelerate BioPharma and the Tufts [...]

    September 22, 2025
  • Drug Development,Patient Centricity,Rare Diseases,Regulatory Affairs

    MHRA approves Biogen’s tofersen for ultra-rare genetic form of motor neurone disease

    The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has [...]

    July 28, 2025
  • Clinical Development,Clinical Trials,Patient Centricity

    Phesi CEO warns of looming Phase 3 trial failures as sponsors overlook real-world data and overcrowd sites

    New analysis reveals billions risked on overly complex trials that [...]

    July 10, 2025
  • Clinical Trials

    Oculis completes enrollment in DIAMOND Phase 3 trials of OCS-01 for diabetic macular edema

    June 4, 2025

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • Symbiosis expands QC capabilities with new 30°C stability chamber
    Categories: CDMOs & Manufacturing, Facilities and infrastructure, Manufacturing, Pharmaceuticals and therapeutics
  • Kainova expands Phase 1/2 trial of DT-7012 with first European patient dosed
    Categories: Clinical Trials, Immunology, Oncology, Research & Development
  • Chemify founder publishes three papers on programmable chemistry and automated drug discovery
    Categories: Artificial Intelligence, Drug discovery, Research & Development, Technology and platforms
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details. OK
Go to Top